[1]Fawcett JW, Asher RA. The glial scar and central nervous system repair [J]. Brain Res Bull, 1999, 49(6): 377-391.
[2]Asher RA, Morgenstern DA, Moon LD, et al. Chondroitin sulphate proteoglycans: inhibitory components of the glial scar[J]. Prog Brain Res,2001, 132:611-619.
[3]Moon LD, Asher RA, Rhodes KE, et al. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC[J]. Nat Neurosci,2001, 4(5):465-466.
[4]Sicotte M, Tsatas O, Jeong SY, et al. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord [J]. Mol Cell Neurosci, 2003, 23(2): 251-263.
[5]Fitch MT, Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure [J]. Exp Neurol, 2008, 209(2): 294-301.
[6]Kawano H, Kimura-Kuroda J, Komuta Y, et al. Role of the lesion scar in the response to damage and repair of the central nervous system [J]. Cell Tissue Res, 2012, 349(1): 169-180.
[7]Bundesen LQ, Scheel TA, Bregman BS, et al. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats [J]. J Neurosci, 2003, 23(21): 7789-7800.
[8]Kimura-Kuroda J, Teng X, Komuta Y, et al. An in vitro model of the inhibition of axon growth in the lesion scar formed after central nervous system injury[J]. Mol Cell Neurosci, 2010,43(2): 177-187.
[9]Rolls A,Shechter R, Schwartz M. The bright side of the glial scar in CNS repair[J]. Nat Rev Neurosci,2009, 10(3):235-241.
[10]Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation[J]. Trends Neurosci,2009, 32(12):638-647.
[11]Yiu G, He Z. Glial inhibition of CNS axon regeneration[J]. Nat Rev Neurosci. 2006, 7(8):617-627.
[12]Faulkner JR, Herrmann JE, Woo MJ, et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury [J]. J Neurosci, 2004, 24(9): 2143-2155.
[13]Yoshioka N, Kimura-Kuroda J, Saito T,et al. Small molecule inhibitor of type I transforming growth factor-β receptor kinase ameliorates the inhibitory milieu in injured brain and promotes regeneration of nigrostriatal dopaminergic axons[J].J Neurosci Res, 2011, 89(3):381-393.
[14]Lagord C, Berry M,Logan A. Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord [J]. Mol Cell Neurosci, 2002, 20(1): 69-92.
[15]Goldshmit Y, McLenachan S, Turnley A. Roles of Eph receptors and ephrins in the normal and damaged adult CNS[J]. Brain Res Rev, 2006, 52(2):327-345.
[16]Rhodes KE, Fawcett JW. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS [J]? J Anat,2004, 204(1):33-48.
[17]Shen LH, Li Y, Gao Q, et al. Down-regulation of neurocan expression in reactive astrocytes promotes axonal regeneration and facilitates the neurorestorative effects of bone marrow stromal cells in the ischemic rat brain [J]. Glia, 2008, 56(16): 1747-1754.
[18]Naima J, Sari SH. Transforming growth factor β-induced expression of chondroitin sulfate proteoglycans is mediated through non-Smad signaling pathways [J]. Exp Neurol, 2015,263:372-384.
[19]Davies JE, Tang X, Denning JW, et al. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries[J]. Eur J Neurosci, 2004, 19(5):1226-1242.
[20]Alonso G. NG2 proteoglycan-expressing cells of the adult rat brain: possible involvement in the formation of glial scar astrocytes following stab wound[J]. Glia, 2005,49(3):318-338.
[21]Buss A, Pech K, Kakulas BA, et al. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury [J]. BMC Neurol, 2009, 9: 32.
[22]Smith GM, Rutishauser U, Silver J, et al. Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth [J]. Dev Biol, 1990, 138(2): 377-390. |